Statins in nonalcoholic fatty liver disease and steatohepatitis: Updated review

Keyphrases

• Non-alcoholic Fatty Liver Disease (NAFLD) 100%
• Statins 100%
• Liver Steatohepatitis 100%
• Review Update 100%
• Nonalcoholic Steatohepatitis 37%
• Cardiovascular Disease 25%
• Hepatic Steatosis 25%
• Risk Factors 12%
• Alcohol 12%
• Weight Loss 12%
• Human Studies 12%
• Fibrosis 12%
• Hepatocellular Carcinoma 12%
• Most Common Cause 12%
• Cirrhosis 12%
• Chronic Liver Disease 12%
• Hepatic Fibrosis 12%
• Lifestyle Modification 12%
• Disease Foci 12%
• Asymptomatic Diseases 12%
• Multifactorial Treatment 12%
• Causes of Mortality 12%

Medicine and Dentistry

• Steatohepatitis 100%
• Nonalcoholic Fatty Liver 100%
• Statin 100%
• Cardiovascular Disease 18%
• Fatty Liver 18%
• Fibrosis 9%
• Hyperlipidemia 9%
• Human Study 9%
• Chronic Liver Disease 9%
• Hepatocellular Carcinoma 9%
• Liver Cirrhosis 9%
• Liver Fibrosis 9%
• Asymptomatic Disease 9%
• Lifestyle 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 100%
• Nonalcoholic Fatty Liver 100%
• Cardiovascular Disease 18%
• Fatty Liver 18%
• Ethanol 9%
• Human Study 9%
• Liver Cell Carcinoma 9%
• Chronic Liver Disease 9%
• Liver Cirrhosis 9%
• Hyperlipidemia 9%
• Liver Fibrosis 9%
• Asymptomatic Disease 9%
• Fibrosis 9%